1 year return (CAGR)
38.90%
Cytokinetics Inc Exchange (NASDAQ, USD)
CYTK
67.59
+0.03 (+0.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
25.46%
5 year return (CAGR)
15.35%
10 year return (CAGR)
22.04%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.40B
Price/Sales
132.42
Ent value
11.24B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
27.07%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 68.07 |
| Daily high | 69.56 |
| Daily low | 67.48 |
| Daily Volume | 2.39M |
| All-time high | 108.06 |
| 1y analyst estimate | 109.90 |
| Beta | 0.38 |
| EPS (TTM) | -6.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CYTK | S&P500 | |
| Current price drop from All-time high | -37.45% | -0.58% |
| Highest price drop | -97.09% | -56.47% |
| Date of highest drop | 10 Oct 2014 | 9 Mar 2009 |
| Avg drop from high | -75.40% | -10.68% |
| Avg time to new high | 1127 days | 12 days |
| Max time to new high | 4952 days | 1805 days |
News
